Cost-effectiveness of the treatment of sickle cell anemia with hydroxyurea: an economic evaluation study
HTML
HTML (Español (España))
HTML (Português (Brasil))
EPUB
EPUB (Español (España))
EPUB (Português (Brasil))
PDF
PDF (Español (España))
PDF (Português (Brasil))

Keywords

Análisis Costo-Beneficio
Anemia Falciforme
Hidroxiurea
Hemoglobina Falciforme
Costos y Análisis de Costo. Cost-Benefit Analysis
Anemia
Sickle Cell
Hydroxyurea
Hemoglobin Sickle
Costs and Cost Analysis. Análise Custo-Benefício
Anemia Falciforme
Hidroxiureia
Hemoglobina Falciforme
Custos e Análise de Custo.

PlumX Metrics

Abstract

Objective: to analyze the cost-effectiveness of the treatment of sickle cell anemia (SCA) using hydroxyurea. Method: economic evaluation study, with a quantitative, descriptive and analytical approach, through a retrospective cohort. To be developed in the main reference services in Campo Grande/MS. Through three phases: systematic literature review, with analysis by odds ratio, model of inverse random effect and chi-square; secondary data collection from medical records and DATASUS with chi-square analysis or Fisher’s exact test; cost-effectiveness analysis using the Markov analytical decision model and Student's t test for all variables. This research is approved by the UFMS Ethics Committee, under opinion no. 2,892,100. Expected results: Produce indicators to support the improvement of public policies, assist in decision-making and therapeutic conduct, in addition to promoting the improvement of patients' quality of life.
https://doi.org/10.17665/1676-4285.20196224
HTML
HTML (Español (España))
HTML (Português (Brasil))
EPUB
EPUB (Español (España))
EPUB (Português (Brasil))
PDF
PDF (Español (España))
PDF (Português (Brasil))

References

SILVA EN, SILVA MT, PEREIRA MG. Health economic evaluation studies: definition and applicability to health systems and services. Epidemiol. Serv. Saúde. [internet] 2016 [cited 2018 fev. 20]; 25(1):205-7. Available from: http://www.scielo.br/pdf/ress/v25n1/2237-9622-ress-25-01-00205.pdf

BOU-MAROUN LM, META F, HANBA CJ, CAMPBELL AD, YANIK GA. An analysis of inpatient pediatric sickle cell disease: Incidence, costs, and outcomes. Pediatr Blood Cancer. [internet] 2018 [cited 2018 fev. 20]; 65(1):1–7. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/pbc.26758.

KARNON J, STAHL J, BRENNAN A, CARO JJ, MAR J, MÖLLER J. Modeling Using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force–4. Value Health. [internet] 2012; [cited 2018 fev. 20]; 15(6):821-7. Available from: https://www.valueinhealthjournal.com/article/S1098-3015(12)01658-0/pdf

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2020 Array